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T  cell  receptors  for antigen  and  major  histocompatibility  complex  (MHC) ~ 
determinants  have,  using  anticlonotypic  monoclonal  antibodies  (mAb),  been 
defined on inducer, suppressor, and class I and class II MHC-specific cytotoxic 
T  lymphocytes as T3oassociated molecules of 90 kilodaltons (kD) molecular mass 
(1-8). These cionotypic structures, termed Ti, are comprised of one 49-54 kD 
a and one 43 kD/3 subunit, which are disulfide linked. Peptide mapping analysis 
of isolated Ti a and/3 subunits from clones of differing specificities demonstrated 
that clonally unique peptides as well as shared peptides existed in each subunit, 
thus implying that variable (V) as well as constant (C) domains existed within Ti 
and/3 molecules (5, 9).  Subsequently, N-terminal amino acid sequencing and 
molecular cloning  techniques  led to identification  of the Ti  /3 gene  structure, 
and showed that specific V-, D- (diversity), J- (joining), and C-like segments fuse 
to form an active/3 gene (10-16). These studies also indicated that the N-terminal 
V  domains  were encoded by nucleotides derived from  V,  D, and J  segments. 
Similar  characterization  of Ti  o~ subunits  suggests that  each contains a  unique 
NH2 V domain created by  joining dispersed germline genes (17-21). In addition 
to  the  similarities  between joining  processes  of T  cell  receptor  and  Ig  gene 
segments, both structures manifest distant but clearcut homology at protein and 
DNA levels. 
T  cell receptors, like B cell receptors, must accommodate a myriad of different 
antigenic specificities in order to provide the organism with an efficient system 
for immunologic recognition. Moreover, since T cells generally recognize antigen 
in the context of polymorphic MHC determinants, it is reasonable to assume that 
V  region  structural  diversity of the T  cell population  will  be no less complex 
than that of B lymphocytes. In the case of B cells, five mechanisms account for 
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the generation of diversity: (a) the presence of a multiplicity of germline V gene 
segments;  (b)  combinatorial  diversity, created by association of different gene 
segments during active V  gene formation (V, D, and J  for heavy chain, and V 
and J  for light chain); (c) junctional diversity, created by variation in the joining 
sites of V  gene segments; (d) somatic mutation, created by one or more point 
mutations in assembled V  region genes; and (e) association-mediated diversity, 
arising from association of different heavy and light chain v  region polypeptides 
(22).  Based on the homologies noted above, it is likely that T  cell receptors will 
use similar mechanisms for generation of diversity. In fact, evidence has already 
been provided to indicate that combinational and junctional diversity must exist 
(15-20). 
The heterogeneity of phenotypically and functionally defined T  cell popula- 
tions generated from separate sublineages of cells within the thymus has, how- 
ever, no clearcut precedent in the B cell system. With regard to V  gene usage, 
therefore, it is conceivable that there is either a complex set of rules restricting 
V  gene usage to a  given subset of T  cells or, alternatively, that a  given V  gene 
can be  used in the formation of any clonal T  cell population.  To address this 
issue,  we have identified an anticlonotypic mAb that is reactive with the Ti /3 
subunit  of human  T  cell  tumor  REX  and  2%  of human  peripheral  blood  T 
lymphocytes, and is herein shown to recognize an epitope expressed by members 
of the REX Ti/3 V gene family. Using this mAb and a subcloned complementary 
DNA (cDNA) fragment encoding the REX Ti/3 V  gene as probes,  we demon- 
strate that (a) these V  gene products are not restricted to T4 or T8  subsets or 
functionally characterized inducer, suppressor, or cytotoxic T  lymphocytes; and 
(b)  T  cell clones selected for expression of this set of V  segment products  use 
diverse  Ti  /3  D  and/or JC  segments,  as  well  as  different  Ti  a  genes.  The 
implications of these findings for creation of the T  cell repertoire in general will 
be discussed. 
Materials and Methods 
Phenotypic Analysis of T Cell Surface Proteins.  mAb anti-T3A,  anti-T4A,  anti-T6, anti- 
T8, anti-T 11, and all anticlonotypic antibodies of the anti-Til_6 series were produced and 
used  in  ascites  form,  as  detailed elsewhere  (1,  3,  6-9,  23).  Phenotypic analysis  was 
performed by means of indirect immunofluorescence with mAb and goat anti-mouse 
F(ab')~ fluorescein isothiocyanate (FITC) on an Epics V cell sorter (Coulter Electronics 
Inc., Hialeah, FL). Quantitative histogram comparisons were analyzed on a Coulter EASY 
system, programmed on the basis of mean channel fluorescence (23). 
Derivation of Lymphoid Populations and T Cell Clones.  Mononuclear cells were obtained 
by Ficoll-Hypaque density gradient centrifugation, and were from healthy donors. Post- 
centrifugation pellets were dextran-sedimented to fractionate granulocytes and red blood 
cells, whereas interface cells were rosetted with sheep erythrocytes to yield T  (E  ÷) and 
non-T (E-) cells. Portions of human thymus (age 2 mo to 2 yr) were taken at the time of 
corrective cardiac surgery, and used as a source of thymocytes, as previously described 
(24).  The REX tumor line and Epstein-Barr virus-transformed B lymphoblastoid line, 
Laz 509, were maintained as previously described (3). 
Generation of Anti-Ti3a-reactive  T Cell Clones.  Peripheral blood anti-Ti3A-reactive T 
cells were isolated from two normal individuals, using anti-Ti3A mAb in indirect immu- 
nofluorescence on an Epics V cell sorter. The Ti~A  + cells were then cloned by limiting 
dilution (at I0, 5, 1, or 0.5 cells/well)  in V-bottom microtiter plates containing 0.1 ml of 
5,000-rad irradiated feeder cells (0.50 ×  106 cells/ml autologous whole mononuclear cells 1328  Ti  ~3  VARIABLE  REGION GENE  USAGE 
(I).  Culture  medium  was  RPMI  1640  with  10%  human  serum,  supplemented  with 
glutamine and penicillin-streptomycin (Gibco Laboratories, Grand Island, NY), and con- 
taining phytohemagglutinin (PHA) at 0.25 #g/ml. 
After 12-18 d, clones were transferred into round-bottom microtiter plates containing 
irradiated feeders, and grown in medium supplemented with  10% interleukin  2 (IL-2)- 
containing  supernatants  (1).  Cells  were  expanded  by feeding  every 2-3  d  with  IL-2- 
conditioned medium, and restimulated every 2 wk with irradiated feeder cells and PHA. 
Cloning and recioning of various selected parent cultures were then performed at 0.3 
cells/well, and subclones were grown for >10 mo. 
Functional  T Cell Assays.  Individual mAb were purified from malignant ascites with 
protein  A-Sepharose  (Pharmacia  Fine  Chemicals,  Piscataway,  N  J).  5  mg  of purified 
antibody was coupled  to  1  ml of swollen  CnBr-activated Sepharose 4  B  in  each case. 
Predetermined optimal concentrations of antibody-coupled beads were added to popula- 
tions of 50,000 clonai T  cells in a total volume of 200 t*l of RPMI  1640 containing 10% 
human type AB serum (25).  In other experiments, clones were stimulated by media alone 
or by media supplemented with affinity-purified IL-2 at 1 U/ml (kind gift of Dr. Kendall 
Smith,  Dartmouth  Medical  School,  Hanover,  NH),  with  or  without  Sepharose-bound 
antibody. After a  24- or 72-h incubation at 37°C,  the cultures were pulsed with  1 ~Ci 
[SH]thymidine ([3H]TdR) (Becton Dickinson and Co., Sunnyvale, CA)-and harvested  18 
h  later  on  a  MASH  II  apparatus  (M.  A.  Bioproducts,  Walkersville,  MD).  [SH]TdR 
incorporation was then measured in a scintillation counter (Packard Instrument Co., Inc., 
Downers Grove, IL). Each value represents the mean of triplicates +SD. 
Induction of IgG secretion was determined with 5  ×  104 autologous or allogeneic B 
lymphocytes (E-rosette-negative peripheral blood mononuclear cells treated with anti-T4, 
anti-T8, anti-Mol, and rabbit complement). To these cells were added 2.5 ×  104 cloned 
cells and optimal concentrations of surface-bound mAb. In mixing experiments, 2.5  × 
104 cloned cells of each type were added. Culture conditions and IgG radioimmunoassay 
were identical to those described previously (8). 
The cytotoxicity assay was a standard 4-h cell-mediated lympholysis (CML) system using 
5*Cr-labeiled  Laz 509, in which the effector/target ratio in all experiments was 20:1  (1). 
Concanavalin A (Con A) was used at a final concentration of 25 #g/ml, and added with 
the target cells at the beginning of the CML assay. This Con A-incubation did not affect 
spontaneous 51Cr-release.  _<20% killing was regarded as insignificant lytic activity. 
One-dimensional Isoelectric Focusing (IEF).  Radioactive bands from polyacrylamide gel 
slices, corresponding to l~SI-labelled  a  and 3 subunits, were eluted overnight at 37°C in 
50 mM sodium bicarbonate with 0.05% sodium dodecyl sulfate (SDS), and trichloroacetic 
acid-precipitated  by adding  bovine serum  albumin  as a  carrier.  The  pellet  was  then 
resuspended in the appropriate IEF sample buffer (one volume of "taken up" buffer and 
one volume of "lysis"  buffer), as described by O'Farrell (26).  IEF was performed in a 
horizontal  electrophoresis  apparatus  (LKB  model  2117  Multiphor,  LKB  Instruments, 
Inc.,  Gaithersburg,  MD)  as  described  by the  manufacturer.  Samples  were  loaded  on 
chromatographic paper at the basic end of the gel, and run at 23 W  until the potential 
reached 2,000 V. Gels were then fixed, dried, and exposed for autoradiography. For the 
3 subunit, IEF sample buffer and gel mixture contained a ratio of 10:1:1  of pH 3.5-10, 
5-7, and 6-8 ampholytes (LKB Instruments, Inc.), and for the a  subunit, a  1:1  ratio of 
pH 3.5-5 and 4-6 ampholytes was used. For the latter IEF, the cathode solution contained 
2% ampholytes at pH 5.7. pH gradients were measured in individual 5 mm gel slices, as 
described (26). 
Immunoprecipitation and Peptide Maps.  1251  surface-labelling of ~2 ×  107 cells of each 
clone  was  performed by  the  lactoperoxidase  method  (3).  Immunoprecipitation,  SDS- 
PAGE (polyacrylamide gel electrophoresis), and peptide mapping were done as previously 
described (3). An anti-a C region heteroantiserum was utilized for immunoprecipitation 
of Ti~- T  cell clones (M. Fabbi, O. Acuto, A. Bensussan, C. B. Poole, and E. L. Reinherz, 
submitted for publication). 
Preparation of Ca and Va REX Probes.  A cDNA clone encoding the complete Ti REX 
/3 subunit was isolated and subcioned into pBR322 (p/JREX)  as described (27).  Segments ACUTO  ET  AL.  1329 
of the C (pC/JREX) and V (pV/3REX) region were inserted in pBR322 as follows, pBREX 
was digested with Eco RI, Hind II and Bgl II. Fragments were separated on a preparative 
agarose gel, and those representing the V region nucleotides (~400 basepairs in the Eco 
RI-Hind II fragment) and C region nucleotides (-800 basepairs in the Bgl I]-Eco RI 
fragment) were  purified by electrophoretic  transfer to a  NA  45  DEAE-nitrocellulose 
membrane (Schleicher and Schuell, Inc.,  Keene,  NH). They were subsequently eluted 
with high-salt buffer (1 M NaCI) at 65°C, and ethanol precipitated. V/3 REX and CO REX 
fragments were ligated to Eco RI-cleaved and pbosphatase-treated pBR322. Subsequently, 
the remaining Eco RI and Bgl II sites (pC/JREX) were filled in with Klenow polymerase, 
and the blunt ends were ligated with T4 DNA ligase. For pV/JREX, the Eco RI site of 
pBR322 was filled in, and the blunt end ligated to the already blunt-ended  Hind II end 
of V/3 REX. Competent MC1061 E. eoli cells were transfected, plated, and screened with 
V/3 REX and C/3 REX nick-translated probes (28). 
Northern and Southern Transfers, and Hybridizations.  DNA and RNA were prepared 
by  standard  techniques  (28). DNA  was digested  with  Eco  RI  or  Barn HI  and  size- 
fractionated on agarose  gels, transferred to Gene Screen  Plus (New England  Nuclear, 
Boston, MA) and hybridized to the s2P-labelled V or C region probes. RNA was treated 
with formaldehyde and run on formaldehyde-containing  agarose gels. Before transfer to 
Gene Screen  Plus, gels were soaked in 20x standard sodium citrate for 30 min. After 
transfer, the membranes  were hybridized (at 68°C, with 106-107 cpm/ml), essentially as 
suggested by the manufacturer. V and C region probes were prepared by nick-translation 
of pV/JREX and pC/JREX, respectively (28). 
Results and Discussion 
The structural nature of clonotypic epitopes has not been previously charac- 
terized.  However, anticlonotypic antibodies could, in principle, be directed at 
epitopes representing any of several levels of complexity. One type of epitope 
would be encoded by a single V, D, orJ segment on either the a or/3 Ti subunit. 
A second, more complex epitope might represent either a sequential or confor- 
mational determinant, encoded by several Ti a  or/3 gene segments (i.e.  V and 
D,  D  and J,  etc.).  The  third  and  most complex clonotypic epitope would be 
combinational in nature, created at the sites where at and/3 V domains interact 
with each other.  The latter,  being the most highly ordered clonal specificity, 
would  likely result  in  anticlonotypes reacting with epitopes  represented  very 
infrequently in a  polyclonal T  cell population. In contrast, "first" and perhaps 
"second" cionai epitopes might be found on T  cell clones expressing related but 
nonidentical receptor structures, thus giving rise  to more broadly distributed 
reactivities. 
Reactivity of Anticlonotypic  Antibodies with Lymphoid Populations.  To investigate 
the possibility that some anticlonotypic epitopes might be directed at V  gene- 
encoded specificities, we characterized 20 anticlonotypic mAb, 17 of which were 
directed against five IL-2-dependent T  cell clones of differing specificity, and 3 
of  which were directed at the human T cell tumor line REX (3). For this purpose, 
we examined mAb reactivities on heterogeneous populations of peripheral blood 
T  lymphocytes and thymocytes by indirect immunofluorescence assay with an 
Epics  V  cell  sorter.  This  strategy was  adopted  on  the  assumption that  "first 
order" clonotypic epitopes would be the most highly abundant in heterogeneous 
T  lineage populations of all clonotypic epitopes, and that the V gene segment, 
being  the  largest  of the  gene  segments responsible  for  the  nature  of the  V 
domain, is most likely to encode clonotypic epitopes. 1330  Ti  /3  VARIABLE  REGION  GENE  USAGE 
Of the 20 antibodies tested, 17 were unreactive (<0.1% reactivity) with T  cells 
or thymocytes by this  screening strategy.  In contrast, all  three mAb directed 
against the REX tumor detected 2% of peripheral blood T  lymphocytes. Fig. 1A 
shows  the  profile  of T  cells  with  a  representative  unreactive anticlonotypic 
antibody (anti-Tis) (2T82FS) and a  representative reactive anticlonotypic anti- 
body (anti-Ti3A) (5REX9H5) in indirect immunofluorescence on an Epics V cell 
sorter. As controls, the thymocyte-specific antibody, anti-T6 (negative control), 
and a T  cell-specific antibody, anti-T3, reactive with >95% of T  cells (positive 
control),  were  used.  Quantitative  dot-plot  analysis  (Fig.  1A),  as  well  as  log 
integrated fluorescence analysis  (Fig.  1 B)  indicate  that  a  discrete population 
comprising ~2% of peripheral T  lymphocytes is reactive with anti-Ti3A (as well 
as anti-Ti~B  and anti-Ti3c) (data not shown).  In contrast, <0.1%  of T  cells are 
reactive with anti-Ti5 or anti-T6. 
Further analysis ofanti-Ti~A reactivity is shown in Table I. Note that peripheral 
blood T  lymphocyte populations derived from 30 unrelated individuals were all 
reactive with anti-TisA antibody (2 -  0.5%).  In addition, each of 10 thymocyte 
preparations  tested  yielded detectable anti-Ti3A reactivity (0.5  --+  0.2%).  The 
lower level of surface reactivity on thymocytes is not surprising in view of earlier 
observations  demonstrating  that  only  a  minor  fraction  of thymocytes (~1/3) 
express detectable levels of surface receptors (3).  In contrast, non-T cell prepa- 
rations  from these same individuals were unreactive, demonstrating no more 
reactivity than the anti-T6 control (-0.1). Furthermore, dual laser fluorescence 
analysis with  directly FITC-labelled  anti-Ti3A and  rhodamine isothiocyanate- 
bound to anti-T4 or anti-T8 indicated that this expression was not restricted to 
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FIGURE  1.  Identification of peripheral T  cells reactive with anti-Tis^ anticlonotype. 50,000 
T cells were mixed with anti-Tis (2T82F5), anti-Tis^ (5REX9H5), anti-T6, or anti-T3 antibody 
at a  1:250 dilution of ascites, and subsequently stained with goat anti-mouse-FITC. Analysis 
was performed by dot plot method. The abscissa represents fluorescence intensity, the ordinate, 
cell size, and density of dot pattern corresponds to cell number (A). Log integrated fluorescence 
analysis of anti-Ti3A-reactive cells is also shown (B) for this same population (X, fluorescence 
intensity, Y, cell number, and Z, cell size). Results are representative of 30 different individuals' 
T  cells tested. ACUTO  ET  AL. 
TABLE  ] 
Reactivity of Anti-Ti3A mAb with a Small Fraction ofT Lymphoid 
Cells 
mAb 
Reactivity of tested cells 
Peripheral  T*  Thymus  Non-T  REX 
% 
Control  ~0.1  _0.1  ~0.1  <0.1 
Anti-TisA  2 ± 0.5  0.5 ± 0.2  <_0.1  >95 
Anti-T3  95 "4- 5  30 _  12  <0.1  >95 
Reactivity was determined by quantitative analysis on an Epics V cell 
sorter by previously described methods. Samples tested: peripheral T 
cells (n =  30); thymus (n =  10); non-T cells (n = 5); REX (n =  3). 
*  T4 and T8 subset determinations using dual lazer analysis with directly 
FITC-labelled anti-Ti3^, and biotinylated anti-T4 or anti-T8 antibody 
followed by RITC-avidin incubation showed that 3 ±  1% ofT cells were 
T4+,Ti3A  + and 1 + 0.3% were T8÷,Tis^  ÷ (n = 3). 
TABLE  II 
Phenotype and Function of Anti-Ti3A-reactive  Clones 
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Clone  Donor  Phenotype  Function* 
A  2  T3+,T4÷,T8-,T 11 +  Inducer 
B  2  T3+,T4 +,T8-,T 11 ÷  Inducer 
C  2  T3+,T4 +,TS-,T 11 +  Inducer 
D  2  T3+,T4+,T8-,T 11 +  Cytotoxic 
E  2  T3+,T4+,T8-,T 11 +  Inducer 
F  2  T3 +,T4+,T8  -,T 11 +  Inducer + cytotoxic 
G  2  T3+,T4+,T8-,T 11 +  Inducer 
H*  I  T3+,T4 +,T8-,T 11 +  Inducer 
I*  1  T 34,T4-,T8*,T 11 +  Suppressor 
* Functional analysis used T  cell-dependent B cell lg assay and Con A-lectin 
approximation studies  with  5~Cr-labelled  Laz  509,  an  EBV-transformed  B 
lymphoblastoid line. 
either the T4  or the T8  subset ofT  cells (T4 +, Ti3A  +,  3  --  1%; T8 +, TisA  +,  1  + 
0.3%). 
Biochemical  Analysis  of  Anticlonotypic  Reactivities  on  T4 +  and  T8 ÷  T  Cell 
Clones.  To  understand  the basis of these reactivities at the molecular level, anti- 
Ti3A-reactive cells were  obtained  by fluorescence-activated cell sorting,  cloned 
by  limiting-dilution techniques,  and  subsequently  recloned  at  0.3  cells/well to 
insure  clonality of individual populations.  Since  these  clonal  populations  were 
not  selected on  the  basis of their  antigenic  specificities, initial and  subsequent 
stimulation  of cells  employed  the  T  cell  mitogen,  PHA.  Table  II  shows  the 
results of phenotypic analysis of nine clones derived from two unrelated donors. 
Eight of the nine clones express the T3÷,T4+,T8-,T  1 1 + phenotype, whereas one 
clone expressed the T3+,T4-,T8+,T  11 + phenotype. The  reason for the predom- 
inance of T4 + cells in this sampling is not clear.  However,  it may reflect either 
an  intrinsic  difficulty in  cloning  human  T8 +  cells or,  alternatively, a  random 
sampling artifact due to the small number  of clones tested. Because T4  cells are 1332  Ti  /3  VARIABLE  REGION  GENE  USAGE 
approximately twice as  frequent as  T8  cells  in  the peripheral  T  lymphocyte 
population,  the  dual  fluorescence analysis noted above  does  not  suggest any 
tendency for Ti~A expression to be significantly greater in the T4 population. 
To characterize the molecule reactive with the anti-TiaA antibody on these T 
cell populations, individual clones were surface labelled by the lactoperoxidase 
technique, and after solubilization of membranes, anti-Ti3A-reactive molecules 
were precipitated and analyzed by SDS-PAGE (polyacylamide gel electrophore- 
sis). As shown in Fig. 2, under reducing conditions two bands of molecular mass 
49-52  kD and  43-44  kD  were detected in  the radioautograph of these gels. 
These  species correspond in  size  to  previously defined Ti  a  and  13  subunits, 
respectively. In addition,  although not shown, nonreducing gels of anti-Ti3A- 
precipitable material identified a single species of ~90 kD in all cases. From these 
results, it is clear that anti-Ti3A reacts with a disulfide-linked heterodimer similar 
in structure to receptor molecules that have been previously characterized on 
individual clonal populations. Furthermore, modulation, with anti-T3 antibodies, 
of the T3 molecular complex on these cells resulted in selected loss of anti-TisA 
reactivity, as previously described (7) for T3-associated clonotypes on all other 
human T  cell clones tested (data not shown). 
Functional  Analysis  of Anti-Tisa-reactive  T  Cell Clones.  To  next  determine 
whether the surface structure recognized by the anti-TiaA antibody served as 
receptor for  the  individual  clonal populations  in  triggering cell  function,  we 
characterized  the  ability  of anti-Ti3A  bound  to  Sepharose  to  induce  clonal 
activation (25). The latter was initially assessed by examining the effect of anti- 
Ti3A-Sepharose on T  cell proliferation and subsequent regulatory activities. 
As shown in Table III for clone H, IL-2, anti-T3, and more importantly, anti- 
Ti~A-Sepharose  induced  the  clones  to  proliferate,  as  measured by  [~H]TdR 
incorporation. In contrast, anti-T4-Sepharose and anti-T8-Sepharose failed to 
FIGURE 2.  SDS-PAGE under reducing conditions ofanti-TisA immunoprecipitates from t~l- 
surface-labelled TiaA  + (A-G)  clones. T-X-100 cell lysates (2 x  107 cells) were precipitated three 
times  with  an  irrelevant  mAb  coupled  to  protein  A-Sepharose  beads  and  subsequently 
immunoprecipititated with anti-TisA Sepharose beads as described in Materials and Methods. 
J4C-labelled  markers  (Amersham  Corp.,  Arlington  Heights,  IL) were:  phosphorylase  b  (97 
kD), bovine serum albumin (68 kD), ovalbumin (46 kD), and carboxyl anhydrase (30 kD). ACUTO  ET  AL. 
TABLE  III 
Clonal Proliferation  Induced by Anti-Tis Antibody Bound to Sepharose 
1333 
Stimulus 
[SH]TdR incorporation in clones of: 
H(T4+,Tis  +)  I(T8+,Ti,  +)  a(T4+,Ti,  -) 
Media  53*  309  43 
IL-2  6,502  24,739  8,242 
Anti-T3 Sepharose  13,753  594  27,533 
Anti-T4 Sepharose  73  825  94 
Anti-T8 Sepharose  56  959  88 
Anti-Ti4 Sepharose  102  865  65 
Anti-Tin Sepharose  17,799  493  I07 
Anti-Tis Sepharose + I L-2  18,001  1,294  8,632 
* Numbers represent the mean of triplicate samples. SD _< 10% in all cases tested. 
result in a  proliferative response. Similar findings were obtained with all eight 
different T4+,Ti3 + cional populations tested. These results are in keeping with 
other data (25) indicating that crosslinking of T3-Ti complexes by Sepharose- 
bound mAb or antigen-MHC leads to growth via an IL-2-dependent mechanism 
of most T  cell populations. 
In  the case of the T8+,TisA  + clone I,  only exogenous IL-2  induced clonal 
proliferation. That neither anti-T3 nor anti-TisA-Sepharose triggered a prolif- 
erative response is of interest in light of earlier studies (7)  indicating that T8 ÷ 
suppressor T  cells fail to proliferate after triggering of their T3-Ti  complex. 
This  finding  suggested  that  clone  I  was  derived  from  a  suppressor  T  cell 
population. Also consistent with this notion was the observation that anticlono- 
typic triggering abrogated proliferation of clone I in response to exogenous IL- 
2 during the subsequent 72-h culture period (1,294 vs. 24,739 cpm). 
Table III also shows that the ability of anti-TisA-Sepharose to mediate induc- 
tion of proliferation is restricted to those clones expressing the anti-TisA-reactive 
heterodimer. Thus, anti-Ti~A bound to Sepharose has no effect on proliferation 
of the  T4+,TisA  -  clone a  (medium alone,  43  cpm; anti-TisA-Sepharose,  107 
cpm). Note, however, that antibodies against the monomorphic T3 subunits of 
the antigen-MHC-receptor complex do induce [SH]TdR incorporation (27,533 
cpm). 
To  next determine whether anti-TisA-Sepharose was capable  of triggering 
clonal regulatory activities, its capacity to induce help or suppression of B cell Ig 
was assessed. Control stimulation with anti-T4-Sepharose, known to be incapable 
of activating T  cell regulatory activity (8),  was examined in parallel. Table IV 
shows the results of a representative experiment. As indicated, anti-TisA-Seph- 
arose and anti-T4-Sepharose induced neither B cells nor T  cell clones to secrete 
Ig by themselves. The two representative T4+,TisA  + clones, A and H, specifically 
provided help to B cells in the presence of anti-Tis-Sepharose but not anti-T4- 
Sepharose. In contrast, T8÷,TiaA  ÷ clone I  failed to provide help. More impor- 
tantly, as shown in the mixing experiments, addition of clone I to the mixture 
of clone H  and B lymphocytes abrogated IgG production induced by anti-TiaA 
bound to Sepharose. This effect was not due to cell crowding, since addition of 
the T4+,TisA  + clone A  to the clone H  plus B cell-mixture did not inhibit IgG 1334  Ti  /~  VARIABLE  REGION  GENE  USAGE 
TABLE IV 
Inducer and Suppressor Function of Anti-Ti3-reactive T Cell Clones 
Cell population 
IgG production 
Anti-T4-  Anti-Tia- 
sepharose  sepharose 
ng/ml 
B cells alone*  <50  <50 
Clone A alone  <50  <50 
Clone H alone  <50  <50 
Clone I alone  <50  <50 
Clone A +  B cells  120  4,615 
Clone H  +  B cells  95  3,522 
Clone I +  B cells  <50  <50 
Clone H and clone I +  B cells  <50  120 
Clone A and clone H +  B cells  88  4,888 
* Data is shown for B cells derived from donor 2. Similar data was obtained 
in parallel experiments with B cells from donor  1.  Results are repre- 
sentative of three separate experiments. IgG in supernatants was quan- 
titated by means of solid-phase radioimmunoassay. 
production. Thus, clones A and H are T4 + inducer clones, whereas clone I is, as 
expected, a T8 + suppressor clone. 
Comparable analysis with  the remaining  anti-TiaA-reactive  clones led to the 
results summarized in Table II. Note that all T4 + clones except clone D provided 
help for B cells in this assay, implying that the majority were inducer clones. As 
indicated, this latter clone was found to mediate cytotoxic effector function when 
tested in a lectin-approximation cytotoxic T  lymphocyte assay, as described (see 
Materials  and  Methods).  In  addition,  clone  F  provided  help  for  B  cell  IgG 
production,  and was also found to mediate cytotoxic activity in this same assay 
system.  That a  single clone could provide both inducer and  cytotoxic effector 
function  is  not  without  precedent,  and  implies  that  clonal  T  cells  can  both 
produce inducer  lymphokines and  lytic effector molecules.  In  summary,  func- 
tional analysis of the anti-TiaA-reactive  clones defined six inducer clones,  one 
suppressor  clone,  one cytotoxic effector clone,  and  one clone mediating  both 
cytotoxic effector function and inducer function. Together, the above data imply 
that the heterodimer detected by anti-Ti3A is the T  cell receptor on these clones. 
Anti-Ti3a  Defines  an  Epitope  on  the  REX  V  Gene Product(s).  Immunoprecipi- 
tation  studies  from  biosynthetically  labelled  REX  tumor  cells  had  previously 
shown that a partially glycosylated intracellular form of the Ti/3 subunit (41 kD) 
that was not associated with the a  subunit was always precipitated by anti-Ti3A 
under both reducing (3) and nonreducing conditions (our unpublished observa- 
tion).  These  results  suggested  that  the  antibody  was  recognizing  an  epitope 
expressed on the Ti/3 subunit.  In addition,  the fact that anti-Ti3A reacted with 
2%  of peripheral  T  cells of 100%  of the  individuals  tested (n  =  30)  made  it 
unlikely that  it  recognized  an  allotypic determinant  expressed on  the  V  or C 
domain of the/3 subunit. 
Based on these observations, it appears plausible that anti-Ti3A might detect a 
Ti /3 V  region  epitope shared by the  REX tumor line and a  peripheral  T  cell ACUTO  ET  AL.  1335 
population.  To  test  this  hypothesis,  a  REX  /3 V  gene  probe  was  generated  (as 
described  in  Materials  and  Methods),  32P-labelled,  and  used  as  a  probe  for 
Northern  analysis  with  total  cytoplasmic  RNA  derived  from individual  clonal 
populations.  Fig.  3  shows  the  results  of such  an  analysis.  Note  that  REX  V  /3 
eDNA  hybridized  to  an  RNA  of ~1.3  kilobases  (kb)  in  all  anti-Ti~A-reactive 
clones  (clones  A-G).  In  contrast,  no  RNA  species  were  detected  in  anti-TisA- 
unreactive  clones  (clones a-d)  from the  same donor.  Nevertheless,  these  same 
anti-TisA-unreactive  clones  express  receptor  RNA,  as  indicated  by  positive 
hybridization  with a  Ti/3 C  region  probe,  C/3 REX.  In the  latter  case,  the  1.3 
and  1.0  kb  RNA  are  similar  in  size  to  those  found  in  the  representative  Ti~  + 
clones tested, F and G. This correlation between Ti~a expression and the presence 
of V/3 REX RNA implies that the TisA epitope is encoded by one or more of the 
REX Ti/3 V  genes known to exist in the germline. 
The presence of two molecular species of RNA in the Northern blots of clones 
F and G  RNA probed with C/3 REX contrasts to the single species identified with 
the V/3 REX  probe in  these same clones. This result is not unexpected, due to 
FIGURE 3.  Expression of V/3 REX-related sequences in TisA  + T cell clones, total thymocytes 
and peripheral  T  cells. (top), total cytoplasmic RNA isolated from TisA  + clones (A-G), TisA- 
clones (a-d), REX tumor cell line (1), peripheral  T cells (2), and thymocytes (3) was run on a 
1.3% agarose gel in the presence  of 1.75% formaldehyde,  blotted  onto gene screen filters 
(New England Nuclear) and probed with s2P-labelled  VB REX eDNA. (bottom), total cytoplasmic 
RNA from clones F and G and a-d probed with 3~P-labelled C/3 REX eDNA. Molecular weight 
markers were 28 S and 18 S ribosomal RNA. 1336  Ti  f3 VARIABLE REGION GENE USAGE 
the  fact  that  the  1.0  kb  RNA  species in  T  cells  is  known  to  be a  transcript 
resulting from DJ joining in the absence of VD joining (29). Fig. 3 also indicates 
that V/3 REX-related message is easily detected in REX (Fig. 3, 1), as well as in 
the  unselected  peripheral  blood T  cells (Fig.  3,  2) and  thymocyte population 
(Fig.  3, 3), despite the fact that only a  fraction of cells in the latter two is anti- 
Ti3A-reactive. The greater abundance of V  13 REX-related RNA transcripts in 
thymus as opposed to peripheral  T  cells contrasts  with  the  significantly  lower 
level of surface  expression  of TisA  in  the  former,  and  suggests that  a  sizable 
fraction of RNA has not been translated  and expressed in the form of surface 
protein.  In this regard,  the presence of both a  1.3 and  1.0-1.1  kb messenger 
RNA  (mRNA)  species  in  thymocytes probed  with  a  V  /3  REX  suggests  that 
perhaps  aberrant  splicing  or  premature  termination  of B-message  RNA  may 
exist. Although the C13 REX probe hybridizes with a component of the  1.0-1.1 
kb mRNA species (data not shown), it is possible that some of the lower molecular 
weight species represent primary V/3 transcripts (+D). The precise correlation of 
V/3 REX RNA expression and anti-Ti3A surface reactivity also strongly suggests 
that  the Ti3A epitope is encoded in the REX V  gene family, rather  than,  or in 
addition to D and/or J  segments. 
Heterogeneity  of Ti  a  and/3  Subunits  on Anti-Tisa-reactive  Clones.  Given that 
the majority of T4+,Ti3A clones were phenotypically indistinguishable by existing 
mAb reactivities,  the possibility that each represented daughter  clones derived 
from the same parent cell had not been excluded. It was thus of importance to 
characterize  any similarities  and differences of the Ti ,  and/3 subunits of the 
various clonal populations.  Moreover,  this  would provide further  information 
about the relatedness of Ti/3 V gene products detected by the VI3 REX probe. 
As a first approach,  we immunoprecipitated Ti molecules from surface-labelled 
clonal populations,  separated Ti  ~ and/3 subunits from seven T4+,Ti3A clones 
(derived from a single donor) by SDS-PAGE analysis, and., after elution, subjected 
them to IEF analysis. Fig. 4 shows the results of parallel studies with both a  and 
/3 subunits. The ranges of pI for a  (4.2-4.6) and/3 (5.6-6.6) were consistent with 
previous observations (9). 
It is evident that although some clones had either an a  or/3 chain that focused 
in a  similar fashion with this set of ampholytes, no two clones were identical in 
both. Thus, it is highly unlikely that the various populations were derived from 
the same parent clone.  Note in addition that the sizable difference in pI value 
(up to 1 pH unit) among/3 chains derived from distinct clones, as uncovered by 
this analysis, strongly suggests that such differences in net charge were due either 
to use of different  members of the VI3 REX  gene family,  or,  alternatively,  to 
different D or J  segments. 
To  acquire  more  direct  information  on  the  relatedness  of the  V  regions 
utilized  by  the  Ti3A  +  clones,  two-dimensional  peptide  mapping  analysis  was 
performed on Ti 0z and/3 subunits from several representative T4+,Ti3A + clones, 
and, for comparison, a T4+,Ti3A  -  clone derived from the same donor.  To this 
end, soluble membrane preparations were obtained from externally 125I-labelled 
clones and  immunoprecipitated  with anti-Ti3  and  with  the anti-Ti  a  C  region 
H36 heteroantisera  (Fabbi et al.,  submitted  for publication).  Individual  bands 
corresponding to ~SI-labelled a  and B chains were eluted from one-dimensional ACUTO  ET  AL.  1337 
FIGURE 4.  IEF analysis  of ~2~l-labelled  Ti a and fl subunits from Tis^ clones  (A-G). Numbers 
indicate pl values determined as described in Materials  and Methods. 
SDS-polyacrylamide gels,  subjected to digestion with proteolytic enzymes, and 
the peptides were separated by electrophoresis and chromatography. 
As shown  by peptide maps of/3 chains from anti-TisA-reactive clones A,  E, 
and  B  in  Fig.  5,  each  of these  subunits  is  clearly related.  The  Ti  fl chains of 
clones  A  and  E  are  strikingly  similar,  although  a  few  reproducible  peptide 
differences  were  noted.  A  third  clone,  B,  was  less  similar  to  A  and  E,  but 
nevertheless shared three distinct peptides (arrows). Note that the assignment of 
identity of these  peptides  was  based  on  additional  studies  (not  shown)  where 
peptide maps of the Ti fl chains from clones E and B were run on the same plate. 
Collectively, these data would argue that the V  gene used by clones A and E in 
formation of the Ti fl subunit is most likely the same, whereas, clone B may use 
a  different  Vfl  REX  family member.  Fig.  5  also  shows  that,  as  expected,  a 
representative anti-Ti3A-unreactive clone (a) gave a  Ti fl peptide pattern which 
was totally unrelated to that seen in clones A, B, or E. 
The similarity of the fl subunits of clones A and E supports the idea that these 
clones may have related antigenic specificity. Further support for this possibility FIGURE  5.  Two-dimensional peptide map analysis of 125I-labelled a  and/3 subunits isolated 
from Ti3A  + clones (A, E, and B) and one Ti3A- clone (a). Ti molecule from clone a was isolated 
by means of a rabbit antiserum (H36) that reacts with constant determinants on the Ti t~ chain 
(see text).  Isolated a  and B chains were digested with trypsin and pepsin, respectively, and 
peptides separated by electrophoresis (--) and chromatography (---), as previously described 
(9). Arrows indicate common peptides. The identification of peptides common to B, A, and E 
was made possible by running the/3 map of clones E and B in parallel. 
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comes from analysis of the a  subunits of these two clones, which demonstrates 
that they are highly related. That there is no requirement for relatedness between 
subunits of clones defined by anti-Ti3A,  however, is evident from the peptide 
map analysis of the Ti3A  + clone B. Note that a single peptide migrating  in both 
chromatographic  and electrophoretic dimensions to the middle of each plate is 
a peptide derived from the C region previously shown to be present in all T  cell 
clones regardless of specificity (9). 
The  Ti~A Epitope Is Present on Products of Several REX  V~ Gene  Family Mem- 
bers.  Since it is known  that  the  REX  V  gene family consists of four or more 
members, it was of interest to use restriction analysis of DNA derived from Ti~ + 
and Ti3- clones, in conjunction with the V/3 REX probe, to determine whether 
more than one pattern  of gene segment rearrangement  could be detected (13). 
As shown in Fig.  6  for granulocyte DNA, the germline pattern  of the V/3 REX 
genes in Southern blot analysis contains four bands in Eco RI digest(two weakly 
hybridizing bands, at 8.2 and 6.1  kb, and two strongly hybridizing bands, at 4.7 
and 2.0 kb, respectively). Presumably, one of the two more strongly hybridizing 
bands  contains  the  V/3  REX  gene.  Six  of seven  Ti3  + clones (all  but clone  D) 
showed obvious alterations  in the germline  pattern.  Thus,  for example,  a  new 
band appears  below the V/3 REX  germline  6.1  kb band  in  DNA digests from 
clone A, above the V/3 REX 8.2 kb band in DNA from clone B, whereas in clone 
C, the V/3 REX 2.0 kb band is deleted.  Furthermore,  the loss of the 2.0 kb V/3 
REX band is concomitantly associated with an increase in intensity of the 8.2 kb 
band, perhaps as a result of recombination events that lead to a new overlapping 
restriction  fragment  and  deletion  of the  other  2.0  kb  allele.  Based  on  these 
observations,  it  is  likely  that  anti-Ti3  defines  an  epitope  on  more  than  one 
member of the V/3 REX V gene family, thus consistent with differences in peptide 
FIGURE 6.  Southern hybridization of DNA from Ti3^* and ~I'i3A-- T  cell clones with V/3 REX. 
DNA from T  cell clones A-G, a-d, and autologous granulocytes was digested with Eco R1; 
fragment size separated by agarose gel electrophoresis, transferred to Gene Screen Plus, and 
hybridized with VB REX probe. The size of the germline granulocyte V/3 REX fragments was 
determined by comparison with ~ Hind III markers, and found to be 8.2,  6.1, 4.7, and 2.0 
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maps of Ti/3 subunits from clones A and B, for example. Although not shown, 
rearrangements  of the  V/3 REX  bands  were detected in  Southern  analyses of 
Barn HI digests of clone D. Fig. 6 also demonstrates that DNA from Tis- clones 
a-d is preserved in the germline pattern, further supporting the notion that anti- 
Ti3 recognizes products of the V/3 REX family. 
Implications for T Cell Receptor Structure and Function.  Although clones A and 
E  yielded identical  results  when  their  DNA  was  probed  with  V/3  REX  after 
digestion of DNA with Eco RI (Fig. 6), or Barn HI (data not shown), the observed 
differences  in  IEF  analysis,  and  small  but  reproducible  differences  in  two- 
dimensional peptide map analysis of their Ti a  and/3 chains suggest that they do 
not express identical  receptors.  Aside from the overall similarity  of restriction 
patterns of clones A and E, the heterogeneity in Southern analysis is consistent 
with the idea that there are probably few, if any restrictions on the mechanisms 
that generate combinational and junctional diversity. This is probably also true 
for chain association-mediated diversity as well, given that related Ti/3 V gene 
segments form V domains in association with related and unrelated Ti a subunits 
(Fig.  4).  The  dissimilarities  among  Ti  a  and  /3 subunits  of the  various clones 
demonstrated by IEF and peptide map analysis make it very unlikely that such 
cells have been primed in vivo against a  single antigen.  Rather, it suggests that 
these clonal  populations,  which  use the  REX  Ti  V  gene  segment  family and 
possibly other different D, J, and C segments, are directed at multiple unrelated 
specificities. To date, studies have failed to provide evidence for somatic mutation 
(11). Thus,  it is improbable that the observed differences in Ti a  and/3 chains 
were generated by this mechanism. 
Presumably,  the  constraints  placed  on  Ti~-bearing  molecules  expressed  by 
clones that have been selected by immunization with a specific antigen, as opposed 
to  the  unprimed  T  cells  used  here,  will  yield  a  much  more  restricted  and 
homogeneous V domain, perhaps derived from a single set of Ti/3, V, D, and J 
segments. Assuming that the Ti a  domain is involved in antigen-MHC binding, 
we predict that structural  constraints are also placed on the latter.  Such a  view 
has precedent in the B cell system, where the generation of antibody responses 
to p-azophenylarsonate  has  been  studied  at  the  molecular  level  (29).  In  this 
regard,  the present system may provide a  useful model to examine  the contri- 
bution of one V gene family to the immune repertoire directed against a defined 
antigen. 
The finding that one Ti/3 V gene family contributes to the V  domain of one 
in every 50 nonimmune peripheral blood T  lymphocytes implies that either the 
germline  V  gene  repertoire  is  extremely  limited,  or that  this  single  family is 
frequently  utilized,  analogous  to  the  Vk  21  family  in  the  B  cell  system  (30). 
Support  for the  first  view comes from  recent  studies  (31)  indicating  that  five 
different V  gene probes identified  -30%  of the  total  Ti  /3 cDNA clones in  a 
mouse thymocyte library. In addition, at least one other anticlonotypic antibody, 
specific for a  Sezary tumor  cell,  reacts  with  a  fraction  of peripheral  blood T 
lymphocytes as well (32).  While the specific epitope it recognized has not been 
linked to any particular  V gene segment, such an association appears likely. We 
cannot, however, rule out the possibility that there are many other V genes that 
are infrequently used.  Nevertheless, given the various mechanisms available to ACUTO ET AL.  1341 
T  cells for generating receptor diversity, the finite nature of the Ti /3 V  gene 
pool,  like that of V  gene pools for Ig light and heavy chains, would pose no 
major constraints on receptor heterogeneity. 
The functional analysis of Ti3A  + clones presented herein demonstrates that V 
segments of the REX family can be used by T4 or T8 sublineages, or for that 
matter, functionally defined distinct regulatory and effector populations. Assum- 
ing that this family is a paradigm for other Ti/3 V gene families, these data imply 
that V  gene usage is independent of phenotype and function. If these notions 
are correct, it is unlikely that class I and class II MHC preferences of T8 and T4 
subsets, respectively, are due to usage of different sets of V gene pools. Rather, 
ancillary recognition structures, such as T4 and T8 molecules themselves, may 
give rise to these observed MHC preferences by increasing overall avidity for 
MHC (33-35). Moreover, it is certainly possible that one set of V gene segments 
is used in recognition of multiple distinct antigens. 
The ability to make mAb against members of a particular V gene family should 
aid in understanding V  gene usage and heterogeneity. What additional restric- 
tions antigen places on selection of D and J  elements in conjunction with a given 
set of V genes will also be of interest. 
The reactivity of all three anti-Ti3 clonotypes against the REX tumor, along 
with  2%  of peripheral  T  cells  and  the  lack  of reactivity  of  17  additional 
anticlonotypes directed against other Ti molecules, implies that the former define 
much more frequent V  gene families than the latter.  Nevertheless, we cannot 
rule out the possibility that the lack of reactivity of some of these anticlonotypes 
is  due  to  the  hierarchal  nature  of clonotypic epitopes,  giving rise  to  higher 
degrees of "uniqueness." The reactivity of anti-TisA with T  cells from each of 30 
individuals tested, however, excludes the possibility that this antibody defines an 
allotypic epitope (36).  Such anti-V domain probes should be useful in  under- 
standing the normal and abnormal immune response. 
Summary 
We examine the rules governing Ti/3 variable (V) gene segment usage in the 
formation of T  cell antigen-MHC receptors in diverse regulatory and effector T 
lymphoid subpopulations.  To  this  end,  a  single  Ti  /3  V  gene  family and  its 
products were analyzed. A  monoclonal antibody, termed anti-Ti3A,  which was 
shown to be reactive with an epitope encoded by members of the REX cell line 
Ti/3 V  gene family, and which was expressed on 2% of human T  lymphocytes 
was used in selection of clones from unprimed peripheral T  lymphocytes. Both 
T4  ÷,  as well as T8 ÷ T  cell clones with  inducer, suppressor,  and/or cytotoxic 
function were defined. Southern analysis, isoelectric focusing and two-dimen- 
sional peptide mapping indicated that individual members of the REX V  gene 
family were linked to different Ti/3 diversity and/or joining and constant region 
segments. Moreover, the Ti a  chains of such clones were distinct. These results 
imply that Ti/3 V gene usage is not restricted to any functionally or phenotypically 
defined T  cell subsets, and there is presumably little, if any, restriction on the 
mechanisms that generate combinational, junctional or chain association-medi- 
ated diversity. 
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